AKT1 and cancer: Notably, the upregulated genes in Sox9-expressing cells were significantly enriched in the PI3K/AKT signalling pathway, which is one of the most frequently activated signalling pathways in cancers, showing that SOX9 may have unknown functions relevant to oncology therapy that merit further investigation.